Anixa Biosciences(ANIX) - 2019 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2019 Commission file number 0-11254 | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|-----------------------------------------------------| | Delaware ...